Stocks
PMGC Holdings Inc.ELAB
NASDAQHealthcareBiotechnology$2.71
Price as of · delayed, not real-time
A clinical-stage biopharmaceutical company developing therapies for rare diseases, with a focus on advancing its lead candidate through early-stage trials. Investors track ELAB for its pipeline progress and potential in the orphan drug space, though it has yet to generate revenue.
52W Range: $2.58-$1537.44
Congressional Interest in PMGC Holdings Inc. (ELAB)
No congressional trades have been disclosed for PMGC Holdings Inc. (ELAB) yet. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
0
Unique Politicians
0
Buys
0
Sells
0
Who in Congress Is Trading ELAB?
No congressional trades found for this stock.